Some research I found this morning.. from Adam

[Guest guest]

Hi,

Just to further explain the situation..the reason I am hesitating to

have the ERCP, is because of research I have done that indicates the

risks..I just wanted to send along portion of an article I found

online on the topic. This is not the first reference to these risks

I have found.

>>>>

The diagnosis and management of type III SOD [i would fall into this

category as I do not have a dilated bile duct or elevated enzymes

etc] are most difficult. Invasive procedures should be delayed or

avoided if possible. Trials of anticholinergics, antidepressants,

nonspecific pain relievers, and/or calcium-channel blockers should

precede invasive approaches. The effectiveness of these agents is yet

to be defined. Diagnostic ERCP has NO ROLE in the assessment of these

patients. It is precisely the typical SOD patient profile (young,

healthy female) that is at highest risk for ERCP-induced severe

pancreatitis and even death. Indeed, the risk of complications

exceeds potential benefit in many cases. Therefore, ERCP, if

performed, must be coupled with diagnostic SOM, possible dual

sphincterotomy, and possible pancreatic stent placement. ERCP with

SOM and ES should ideally be performed at specific referral centers

and in randomized controlled trials that examine the impact and

timing of therapeutic maneuvers on clinical outcome

<<<<<<<<<

This was taken from an NIH State of the Science Conference of 2002.

Adam

[Guest guest]

Print it off and take it to your GI appointment and ask to have all the

other avenues tried before having the ERCP done.

What type of IV are you having when in the hospital? You aren't letting

them give you ringers are you?

adamm4321 wrote:

>Hi,

>

>Just to further explain the situation..the reason I am hesitating to

>have the ERCP, is because of research I have done that indicates the

>risks..I just wanted to send along portion of an article I found

>online on the topic. This is not the first reference to these risks

>I have found.

>

>

>

>The diagnosis and management of type III SOD [i would fall into this

>category as I do not have a dilated bile duct or elevated enzymes

>etc] are most difficult. Invasive procedures should be delayed or

>avoided if possible. Trials of anticholinergics, antidepressants,

>nonspecific pain relievers, and/or calcium-channel blockers should

>precede invasive approaches. The effectiveness of these agents is yet

>to be defined. Diagnostic ERCP has NO ROLE in the assessment of these

>patients. It is precisely the typical SOD patient profile (young,

>healthy female) that is at highest risk for ERCP-induced severe

>pancreatitis and even death. Indeed, the risk of complications

>exceeds potential benefit in many cases. Therefore, ERCP, if

>performed, must be coupled with diagnostic SOM, possible dual

>sphincterotomy, and possible pancreatic stent placement. ERCP with

>SOM and ES should ideally be performed at specific referral centers

>and in randomized controlled trials that examine the impact and

>timing of therapeutic maneuvers on clinical outcome

><<<<<<<<<

>

>

>This was taken from an NIH State of the Science Conference of 2002.

>

>Adam

>

>

>

>

>Medical advice, information, opinions, data and statements contained herein are

not necessarily those of the list moderators. The author of this e mail is

entirely responsible for its content. List members are reminded of their

responsibility to evaluate the content of the postings and consult with their

physicians regarding changes in their own treatment.

>

>Personal attacks are not permitted on the list and anyone who sends one is

automatically moderated or removed depending on the severity of the attack.

>

>